UMIN000050659Not yet recruiting
Efficacy of pharmacist intervention for a patient who takes incretin modulator.
Chiba Pharmaceutical AssociationUniversity Hospital Medical Information Networkbehavioral
VerifiedUniversity Hospital Medical Information Network
Study focus
- Disease/Condition
- Diabetes mellitus
- Study type
- Interventional
- Intervention type
- behavioral
Sponsor & location
- Primary sponsor
- Chiba Pharmaceutical Association
- Location
- Japan
Timeline & enrollment
- Phase
- N/A
- Start date
- Apr 01, 2023
- End date
- N/A
ICD-10 classifications
Diabetes mellitusUnspecified diabetes mellitusOther specified diabetes mellitusUnspecified diabetes mellitus without complicationsUnspecified diabetes mellitus with unspecified complications
Data source
- Registry
- University Hospital Medical Information Network
- Trial ID
- UMIN000050659
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for UMIN000050659 through Pure Global AI's free database. This phase not specified trial is sponsored by Chiba Pharmaceutical Association and is currently Not yet recruiting. The study focuses on Diabetes mellitus.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.